Hewlett Packard Enterprise Company (HPE) Company Bio
Hewlett Packard Enterprise Company offers IT consulting and technology services. The company was founded in 2014 and is based in Palo Alto, California. Hewlett Packard Enterprise Company operates as a subsidiary of Hewlett-Packard Company.
HPE Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for HPE, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Hewlett Packard Enterprise Co ranked in the 39th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for HPE, they are:
The stock's equity weight, or the proportion of capital from equity relative to debt, is 48. Notably, its equity weight is greater than merely 7.43% of US equities in the Technology sector yielding a positive free cash flow.
Its compound free cash flow growth rate, as measured over the past 4.69 years, is -0.16% -- higher than only 12.45% of stocks in our DCF forecasting set.
Hewlett Packard Enterprise Co's weighted average cost of capital (WACC) is 6%; for context, that number is higher than just 4.52% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
IAC, ROG, TXN, ACN, and ADBE can be thought of as valuation peers to HPE, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.
The number of deaths from the coronavirus that causes COVID-19 rose above 353,000 on Wednesday, as the World Health Organization said the Americas are at the center of the pandemic following surges in infections in Brazil, Peru, Chile and others in the past few days.
The U.S. death toll from the coronavirus that causes COVID-19 edged closer to 100,000 on Friday, as the news emerged that the Centers for Disease Control and Prevention has been combining the results of two different types of tests for the illness in a move that has been sharply criticized by health experts.